pharma
Japan’s Oncolys invests £3m in adenovirus firm Unleash Immuno Oncolytics
February 20, 2018Manufacturing and Production, Research and Development, Sales and Marketing Oncolys, Unleash Immuno Oncolytics, pharma
Unleash Immuno Oncolytics, a US firm focusing on the development of viral biologics in the treatment of cancer, has attracted …
Lilly dumps Hanmi’s rheumatoid arthritis med
February 20, 2018Manufacturing and Production, Sales and Marketing Eli Lilly, arthritis, hanmi, pharma
Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, …
Patient experience: Living with multiple myeloma
February 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, mutiple myeloma, patient experience, pharma
Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …
Apricus shares sink after failed erectile dysfunction application
February 19, 2018Sales and Marketing Apricus, biotech, drugs, pharma, pharmaceutical
Apricus Biosciences had a lot riding on its application to the FDA for its erectile dysfunction cream, Vitaros, with the …
Janssen’s Tremfya shows long-term efficacy in moderate to severe plaque psoriasis
February 19, 2018Research and Development, Sales and Marketing Janssen, Tremfyam guselkumab, pharma, plaque psoriasis, psoriasis
Janssen has unveiled new Phase 3 trial data for its IL-23 inhibitor Tremfya (guselkumab), demonstrating that the drug was able …
Celgene reveals strong P3 Otezla data in rare inflammatory condition
February 19, 2018Research and Development, Sales and Marketing Behçet's disease, Celgene, apremilast, otezla, pharma
Celgene has lifted the curtain on strong new Phase 3 data for its phosphodiesterase 4 (PDE4) inhibitor Otezla (apremilast) in …
Long-running, $2.5bn lawsuit swings in Gilead’s favour
February 19, 2018Sales and Marketing Gilead, MSD, biotech, drugs, harvoni, pharma, pharmaceutical, sovaldi
The fate of pharma company’s profits and losses largely rests on product approvals and the sales team behind them but, …
AZ’s Imfinzi seals blockbuster lung cancer market with FDA nod
February 19, 2018Sales and Marketing AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical
AstraZeneca’s immunotherapy, Imfinzi, arrived to the industry as a failure – there were big hopes resting on the company’s Mystic …
Top Ten most popular articles on Pharmafile.com this week
February 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical
Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …
FDA weighs up divisive change to Alzheimer’s drug assessment
February 16, 2018Medical Communications Alzheimer's, FDA, biotech, drugs, pharma, pharmaceutical
Alzheimer’s disease (AD) is an area badly in need of a treatment, the problem is that this prospect seems to …
Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health
February 16, 2018Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma
Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …
Silicon Valley-backed Celgene spin-off launches with $250m
February 16, 2018Medical Communications, Sales and Marketing Celgene, Celularity, biotech, drugs, pharma, pharmaceutical
Biotechs are known for getting off the ground early with serious levels of financing, often based more on the acumen …
Biogen shares hit by key Alzheimer’s drug concerns
February 15, 2018Research and Development Alzheimer's, Biogen, MSD, Merck, biotech, drugs, pharma, pharmaceutical
Biogen made investors very nervous after it announced that it was choosing to add an additional 510 patients to its …
Celltrion’s Herceptin biosimilar seals EU approval
February 15, 2018Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma
Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …
J&J’s apalutamide scores snap FDA approval in castration-resistant prostate cancer subgroup
February 15, 2018Sales and Marketing Cancer, Erleada, FDA, J&J, JJ, Johsnon & Johnson, apalutamide, pharma, prostate cancer
Johnson & Johnson has announced that its androgen receptor inhibitor apalutamide, now branded as Erleada, has received approval from the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
